Introduction

Collagen-stimulating injectables are designed to support gradual tissue remodelling rather than create only an immediate filling effect. At Millennium Clinic Kuala Lumpur, a doctor-led consultation and facial assessment can help determine whether Lenisna or another treatment is appropriate for a patient’s skin condition, facial structure and aesthetic goals.

Lenisna is an injectable formulation containing poly-D,L-lactic acid, commonly abbreviated as PDLLA, and non-cross-linked hyaluronic acid. The hyaluronic acid provides an initial hydrating or temporary plumping effect, while PDLLA particles are intended to trigger a controlled tissue response that supports new collagen formation over time.

Understanding how Lenisna stimulates collagen is important because it is not the same as simply placing a conventional hyaluronic acid filler beneath a wrinkle. Improvement from a collagen biostimulator is expected to develop gradually, and individual results depend on age, skin quality, treatment area, injection technique, lifestyle and biological response.

 

Image credit: Gustavo Fring via Pexels.

Key Takeaways

What Is Lenisna?

A PDLLA and hyaluronic acid injectable

Lenisna is a hybrid injectable combining:

• Poly-D,L-lactic acid microparticles;
• Non-cross-linked hyaluronic acid; and
• A carrier solution used to distribute the product during injection.

PDLLA belongs to a family of biodegradable synthetic polymers used in medical and aesthetic applications. The material gradually breaks down after injection while the surrounding tissue responds to its presence.

Hyaluronic acid is a naturally occurring component of the extracellular matrix. It attracts and holds water, although the behaviour and duration of an injectable HA product depend on its concentration, molecular characteristics and whether it is cross-linked.

Its role as a collagen-stimulating injectable

Lenisna is usually described as a collagen biostimulator because its main intended effect is not limited to the volume of product physically placed in the skin. Instead, the PDLLA component is intended to encourage a controlled biological response associated with new collagen formation.

A collagen-stimulating injection should not be confused with an injection of collagen itself. The product does not simply replace all missing collagen. It creates a local environment in which the patient’s own tissue may gradually produce and reorganise collagen.

Preclinical research has found that PDLLA injections can increase collagen-related tissue changes over time. However, findings from laboratory or animal studies cannot predict an identical response in every human patient. Product formulation, particle characteristics, injection depth and individual biology all matter.

How Lenisna differs from traditional volume fillers

Traditional cross-linked hyaluronic acid dermal fillers are gels that provide immediate physical volume. They may be used to reshape a specific feature, support tissue or fill a defined depression.

Lenisna can cause an early change because of its carrier, hyaluronic acid, treatment fluid and temporary swelling. Nevertheless, its principal aesthetic concept is gradual collagen biostimulation rather than precise, immediate contouring alone.

This distinction affects expectations. A patient seeking immediate lip definition or highly controlled structural projection may require a different product. A patient seeking progressive support for broader skin laxity or volume loss may be considered for a biostimulatory approach.

Why collagen stimulation matters in aesthetic medicine

As the skin ages, collagen fibres become fragmented and collagen production becomes less efficient. Supporting gradual collagen remodelling may help improve firmness, elasticity and tissue quality in appropriately selected patients.

Collagen stimulation cannot stop ageing. It also cannot correct every type of facial concern. Bone changes, fat-pad movement, muscle activity, skin pigmentation and severe tissue descent may require different or additional approaches.

Understanding Collagen and Skin Ageing

What is collagen?

Collagen is a family of structural proteins found throughout the body. In the skin, collagen fibres form an important part of the dermal extracellular matrix, helping provide strength and structural support.

Fibroblasts are the main skin cells responsible for producing collagen and other extracellular-matrix components. Type I and type III collagen are particularly relevant to dermal structure and wound healing.

How collagen supports the skin

A healthy collagen network helps the skin:

• Resist mechanical stress;
• Maintain dermal thickness;
• Support elasticity together with elastin;
• Provide a structural framework for cells and blood vessels; and
• Recover from everyday movement and environmental exposure.

Collagen is not solely responsible for youthful-looking skin. Hyaluronic acid, elastin, fat, bone, muscle and the skin barrier also influence appearance.

Why collagen production declines

Chronological ageing changes fibroblast activity and the organisation of the extracellular matrix. Existing collagen becomes more fragmented, while the production of new collagen becomes less efficient.

A detailed review of biochemical and structural changes in ageing human skin reports that intrinsic ageing is associated with reduced collagen synthesis and changes in collagen organisation. This contributes to thinner, less resilient skin.

Hormonal changes, particularly around menopause, may also affect collagen content and skin thickness. The rate of change is not identical for every person.

Environmental and lifestyle factors

Ultraviolet radiation is a major contributor to premature skin ageing. Repeated UV exposure activates enzymes that degrade collagen and interferes with normal collagen production.

The American Academy of Dermatology recommends sun protection and avoiding smoking to reduce premature skin ageing. Kuala Lumpur’s strong year-round UV exposure makes consistent sunscreen use relevant even after aesthetic treatment has finished.

Factors associated with faster visible ageing may include:

• Repeated unprotected sun exposure;
• Smoking;
• Air pollution;
• Poor-quality sleep;
• Chronic stress;
• Excessive alcohol intake;
• Inadequate nutrition; and
• Repeated inflammation or skin injury.

Good lifestyle habits cannot reverse major volume loss, but they can help protect existing collagen and support general skin health.

How collagen loss affects appearance

Changes in collagen and the wider facial structure may contribute to:

• Fine lines and wrinkles;
• Reduced firmness;
• Skin laxity;
• Less defined facial contours;
• Enlarged-looking pores;
• Rough or uneven texture; and
• Reduced elasticity.

Atrophic acne scars are also associated with collagen damage and insufficient tissue repair. However, acne scars vary in structure. A collagen biostimulator may support selected depressed scars, but tethered rolling scars may require subcision, while deep ice pick scars may need focal treatment.

How Lenisna Stimulates Collagen

The science behind collagen biostimulation

Biostimulation refers to using a material or controlled treatment to encourage the body’s own repair and remodelling processes.

After Lenisna is injected into a suitable tissue plane, PDLLA particles remain temporarily within the treated area. The body recognises the particles as a biodegradable material and begins a controlled local response.

Cells involved in repair and material clearance gather around the particles. These may include macrophages and fibroblasts. Chemical signals released during this process can encourage extracellular-matrix production and remodelling.

This is a controlled foreign-body response, not unrestricted inflammation. Appropriate dilution, preparation, placement and dosage are important because an excessive or poorly distributed response may contribute to nodules or irregularity.

The role of PDLLA

Poly-D,L-lactic acid consists of both D- and L-lactic-acid forms. This gives PDLLA an amorphous structure that differs from poly-L-lactic acid, or PLLA.

PDLLA microspheres are intended to act as temporary scaffolding or biostimulatory particles. As the body processes them, local cellular activity may encourage collagen deposition around the treated area.

A preclinical study of PDLLA in aged skin found increasing collagen density over time in treated animal tissue. This supports the biological rationale for PDLLA, but it remains important to distinguish preclinical evidence from large, long-term human trials.

A more recent randomised split-face clinical study of a PDLLA and non-cross-linked HA injectable reported gradual improvement in nasolabial-fold severity after a series of treatments. The study was relatively small and evaluated a specific indication and protocol, so its findings should not be generalised to every treatment area or patient.

The role of hyaluronic acid

Hyaluronic acid binds water and contributes to tissue hydration and viscoelasticity. In Lenisna, the non-cross-linked HA component helps suspend and distribute the PDLLA particles.

It may also provide temporary hydration or initial plumping. Because it is non-cross-linked, it should not be assumed to behave like a dense structural HA filler designed for prolonged projection.

Any immediate fullness may be partly related to:

• Injected treatment fluid;
• Temporary swelling;
• Water attraction by HA; and
• Physical placement of the product.

Some of this initial effect may reduce as swelling settles and HA is metabolised. The later response is expected to depend more on tissue remodelling.

How the body produces new collagen

Fibroblasts manufacture precursor molecules that are assembled into collagen fibres. These fibres undergo organisation and cross-linking within the extracellular matrix.

Following a controlled biostimulatory signal, fibroblasts may increase matrix production. New collagen is then deposited and remodelled. The process is gradual because cells need time to manufacture, organise and mature the tissue.

The result is not equivalent to installing a solid implant. It is a biological response whose extent differs among patients.

Why improvement develops gradually

A traditional filler may create an immediately visible contour because the injected gel occupies space. Collagen biostimulation depends on cell activity and tissue remodelling, so the more meaningful effect generally develops over weeks or months.

Patients should avoid judging their final result during the first few days. Initial swelling may temporarily exaggerate the effect, while a later reduction in swelling may make it seem that the result has disappeared before collagen changes become apparent.

Skin remodelling after treatment

Remodelling can be understood in simplified stages:

1. Initial placement: The product and treatment fluid occupy the injection area.
2. Early response: Mild inflammation and cellular recruitment occur around the particles.
3. Fibroblast activity: Repair signals encourage extracellular-matrix production.
4. Collagen deposition: New collagen forms around the treated tissue.
5. Maturation: Collagen fibres reorganise while PDLLA gradually degrades.
6. Longer-term change: Tissue quality or support may improve, depending on the patient’s response.

This process should remain controlled. Persistent redness, pain, increasing swelling or firm lumps require medical review.

Collagen Production Timeline

This timeline is illustrative. It is not a guarantee that every patient will see improvement at the same stage.

 

Image credit: Hanna Pad via Pexels.

Areas That May Be Treated With Lenisna

Potential treatment areas include the following, depending on local product indications and individual assessment.

Cheeks

Lenisna may be considered for broad cheek support, mild volume loss or skin-quality concerns. Injection depth and placement must account for facial vessels, fat compartments and asymmetry.

Temples

Temple hollowness can contribute to an aged or tired appearance. The temple contains important blood vessels and nerves, making it a technically sensitive area that requires an experienced medical injector.

Jawline and lower face

Selected patients may seek gradual improvement in lower-face support or mild laxity. Lenisna cannot reproduce the effect of surgery and may be insufficient for substantial tissue descent or heavy jowling.

Acne scars

An acne scar collagen treatment may help selected shallow or broad depressed scars. However, injectable biostimulation is only one possible component of acne scar care.

Tethered rolling scars may require subcision. Deep boxcar or ice pick scars may need focal techniques, fractional CO₂ laser, Sylfirm X or another RF microneedling treatment. Many patients have mixed scars requiring a combined plan.

Skin texture and laxity

Lenisna may be considered when the goal is progressive improvement in firmness, elasticity or texture. It should not be presented as a guaranteed pore-erasing or lifting treatment.

Overall facial rejuvenation

A whole-face plan may consider bone structure, fat distribution, skin quality and facial movement. Lenisna may be one part of that plan alongside skincare, skin boosters, Rejuran, energy-based treatment or conventional dermal fillers.

Who May Be Suitable for Lenisna?

Potential candidates may include adults with:

• Early or moderate signs of facial ageing;
• Mild-to-moderate facial volume loss;
• Reduced firmness or elasticity;
• Selected areas of skin laxity;
• Suitable depressed acne scars;
• A preference for gradual, natural-looking change;
• An interest in collagen stimulation rather than instant contouring; and
• Realistic expectations about multiple sessions and variable results.

Suitable vs Unsuitable Candidates

The table is a general guide. Only a medical consultation can determine individual suitability.

Treatment Procedure

Consultation

The doctor should ask about:

• Medical conditions;
• Allergies;
• Pregnancy or breastfeeding;
• Autoimmune or inflammatory illness;
• Previous filler or biostimulator injections;
• Medicines and supplements;
• Bleeding or bruising tendency;
• Cold sores or active infection; and
• Previous aesthetic complications.

Patients should disclose all previous facial injections, even if they were performed years earlier.

Facial assessment

Assessment may include facial proportions, skin quality, asymmetry, volume distribution and movement. Standardised photographs may be taken for treatment planning and follow-up.

The doctor should distinguish concerns that Lenisna may improve from those better treated with another method.

Treatment planning

The plan determines:

• Treatment areas;
• Product preparation;
• Injection depth;
• Amount per session;
• Number and spacing of sessions;
• Whether other treatments are needed; and
• Expected recovery.

More product does not automatically produce a better result. Appropriate distribution is central to safety.

Injection process

The skin is cleansed, and topical or injected anaesthetic may be used according to the protocol. The doctor then places the prepared product using a needle or cannula.

Patients may feel pressure, stinging or mild discomfort. The exact technique varies with the area and intended treatment depth.

Treatment duration

An appointment may take approximately 30–60 minutes, including preparation, assessment and injection. More complex plans may take longer.

Number of sessions

Some patients may undergo two or three sessions separated by several weeks, while others may need a different plan. Session numbers should not be sold as a universal package without assessment.

Follow-up visits

Follow-up helps the doctor monitor:

• Swelling and bruising;
• Symmetry;
• Early nodules or irregularity;
• Collagen-related improvement;
• Whether further treatment is justified; and
• Whether the treatment plan should be changed.

Treatment Journey Timeline

How Long Does It Take to See Results?

Immediate appearance

The face may look temporarily fuller immediately after treatment. This is not entirely new collagen. It may be related to fluid, HA and swelling.

Gradual collagen production

Collagen-related changes usually take longer. Some patients notice progressive improvements after several weeks, with further development over the following months.

Why patience matters

Repeated treatment too early may expose the patient to unnecessary product and inflammation before the full response is visible. Follow-up photographs should be reviewed under consistent lighting.

Age, baseline collagen, smoking, sun exposure, general health and treatment technique can all influence the response.

Potential Benefits

Possible benefits may include:

• Improved skin firmness;
• Better elasticity;
• Gradual support in areas of volume loss;
• Smoother-looking skin texture;
• Natural-looking progression;
• Improvement in selected depressed acne scars;
• Broader facial rejuvenation; and
• Longer-term collagen support after the initial HA effect subsides.

These are potential outcomes, not promises. Some patients experience modest improvement, and others may not achieve their intended result.

Limitations

Lenisna has important limitations:

• Results vary between patients;
• Several sessions may be needed;
• Improvement is gradual;
• It cannot precisely contour every feature;
• It does not replace surgery for substantial laxity;
• It cannot release every tethered acne scar;
• It may not correct pigmentation or active acne;
• Nodules or irregularity can occur; and
• Long-term product-specific evidence remains less extensive than for some established treatments.

A balanced consultation should discuss alternatives, including choosing no injectable treatment.

Lenisna vs Traditional Dermal Fillers

Neither option is universally better. The appropriate choice depends on anatomy and treatment goals.

Can Lenisna Be Combined With Other Treatments?

Combination treatment should have a clear purpose. Performing several procedures without proper sequencing can increase inflammation and complications.

Skin boosters and Juvelook

Skin boosters may address hydration or superficial skin quality. Juvelook also contains PDLLA and HA but is generally used with different treatment depths or objectives. Combining similar biostimulators requires particular caution to avoid excessive product or inflammation.

Sylfirm X

Sylfirm X is an RF microneedling platform used to create controlled tissue stimulation. A doctor may separate it from Lenisna treatment to allow inflammation to settle and to evaluate the response.

Fractional CO₂ laser

Fractional CO₂ laser may improve surface texture and selected acne scars. It creates more visible downtime and should generally be coordinated carefully with injectable treatment.

Pico laser

Pico laser treatment may target pigmentation or, with certain handpieces, texture. It does not provide the same structural support as an injectable collagen stimulator.

HIFU

High-intensity focused ultrasound delivers energy into selected tissue layers. Treatment order should consider swelling, depth and the possibility that energy-based procedures could affect previously injected areas.

PRP

Platelet-rich plasma is prepared from the patient’s blood and may be considered for skin or hair concerns. Protocols vary, and adding PRP does not guarantee a better Lenisna result.

Rejuran

Rejuran products contain polynucleotide-based materials and are generally positioned for skin quality rather than substantial volume. Product indications and injection schedules should be reviewed individually.

Exosome therapy

Exosome products remain an emerging area with variable manufacturing, regulation and evidence. They should not automatically be added to a treatment package.

The safest order and interval depend on treatment intensity, anatomy and healing response.

Safety Considerations

All injections carry risks. Mayo Clinic lists swelling, pain, bruising, infection, contour irregularity, allergic reactions and accidental blood-vessel injection among potential filler complications.

Accidental vascular injection is uncommon but may cause tissue damage, visual impairment or other serious complications. Treatment should therefore be performed by a qualified practitioner who understands anatomy and can recognise and manage emergencies.

Other possible adverse effects include:

• Redness;
• Tenderness;
• Swelling;
• Bruising;
• Itching;
• Asymmetry;
• Palpable lumps;
• Delayed nodules;
• Inflammatory reactions; and
• Infection.

Unlike a purely HA filler, the PDLLA portion cannot simply be dissolved with hyaluronidase.

Pregnancy and breastfeeding

Elective injectable treatments are generally postponed during pregnancy because safety evidence is insufficient. Breastfeeding suitability should also be discussed with the treating doctor.

Autoimmune and inflammatory conditions

An autoimmune diagnosis does not create one universal rule, but it requires careful assessment. Disease activity, medication use and immune response may affect suitability.

Allergies and infection prevention

The doctor should review known allergies and avoid injecting through active acne, dermatitis, herpes or other infection. Sterile technique and correctly sourced products are essential.

 

Image credit: Dr. Haror’s Wellness via Pexels. Image used for general illustration; the exact procedure and product may differ.

Recovery and Aftercare

Mild swelling, tenderness and bruising are common after injectable treatment. These effects often settle gradually, although individual recovery varies.

Massage may be advised for some PDLLA protocols, but patients should only massage the area if their treating doctor specifically instructs them to do so. Technique, frequency and duration depend on product preparation and injection placement.

Lenisna Aftercare Checklist

Do not apply unapproved products to injection sites. Contact the clinic rather than attempting to treat persistent lumps or unusual swelling at home.

Frequently Asked Questions

1. What is the simple explanation of how Lenisna stimulates collagen?

PDLLA particles create a controlled local tissue response. Cells involved in repair interact with the particles, and fibroblasts may gradually produce new collagen around the treated area.

2. Is Lenisna a filler or a collagen stimulator?

It has characteristics of both. Its HA component may provide temporary hydration or fullness, while PDLLA is intended to produce longer-term biostimulation. Its primary positioning is as a collagen-stimulating injectable.

3. Are the immediate results new collagen?

No. Immediate fullness is mainly related to product fluid, HA and swelling. New collagen formation takes weeks or months.

4. How many Lenisna sessions will I need?

Some patients may need a series of sessions, but there is no correct number for everyone. The doctor should decide according to anatomy, response and goals.

5. Is Lenisna suitable for acne scars?

It may support selected depressed scars, but it does not treat every scar type. Tethered rolling scars, deep boxcar scars and ice pick scars may require other procedures.

6. Can Lenisna lift sagging skin?

It may improve mild firmness or tissue support in selected patients. It cannot reproduce a surgical facelift or reliably correct severe laxity.

7. Is treatment painful?

Patients may experience stinging, pressure or tenderness. Anaesthetic may be used, although discomfort varies with the treatment area and technique.

8. What is the typical downtime?

Swelling, redness, tenderness and bruising may last several days. More persistent reactions are possible and should be reviewed medically.

9. Can Lenisna be dissolved?

The HA component may respond to hyaluronidase, but PDLLA particles cannot be removed by simply dissolving them. This is one reason careful placement is essential.

10. Can I combine Lenisna with HIFU or laser treatment?

Possibly, but the procedures should be sequenced by a doctor. Treatment depth, inflammation, recovery and the location of previously injected product must be considered.

11. How long do Lenisna results last?

Duration varies. It depends on the treatment plan, age, collagen response, lifestyle and ongoing ageing. No fixed duration can be guaranteed.

12. How do I choose a provider for Lenisna in Kuala Lumpur?

Choose a doctor-led clinic that assesses your medical history and facial anatomy, explains alternatives, uses authentic products and has a plan for recognising and managing complications.

Supporting Collagen After Treatment

Aesthetic injections are only one part of skin care. Patients can help protect their skin by:

• Applying broad-spectrum sunscreen daily;
• Avoiding smoking;
• Eating a balanced diet with adequate protein;
• Exercising regularly;
• Getting sufficient sleep;
• Managing active acne;
• Using evidence-based skincare; and
• Avoiding unnecessary repeated inflammation.

These habits do not guarantee a stronger treatment response, but they support general skin health and reduce avoidable collagen damage.

Conclusion

Lenisna combines PDLLA particles with non-cross-linked hyaluronic acid. The HA component can provide temporary hydration or early fullness, while PDLLA is intended to produce a controlled tissue response that supports gradual collagen formation. This explains why Lenisna results should be evaluated over months rather than immediately after injection.

Potential benefits include improved firmness, elasticity, skin quality and gradual facial support. Lenisna may also play a role in selected acne scar plans. However, results vary, multiple sessions may be required, and the treatment cannot correct every form of volume loss, laxity or scarring.

Safety depends on proper patient selection, authentic product sourcing, anatomical knowledge, injection technique and follow-up. Patients considering Lenisna treatment Kuala Lumpur should receive a medical assessment rather than selecting treatment through a standard package.

Millennium Clinic Kuala Lumpur is a doctor-led aesthetic clinic offering comprehensive facial assessment, personalised collagen-stimulating treatment planning and evidence-based recommendations. A consultation can determine whether Lenisna, a conventional dermal filler, skin booster, energy-based procedure or a carefully sequenced combination is best suited to the patient’s condition and goals.

References

1. American Academy of Dermatology Association. “11 Ways to Reduce Premature Skin Aging.”
   https://www.aad.org/public/everyday-care/skin-care-secrets/anti-aging/reduce-premature-aging-skin
2. National Library of Medicine, PubMed Central. “Biochemical, Structural and Physical Changes in Aging Human Skin, and Their Relationship.”
   https://pmc.ncbi.nlm.nih.gov/articles/PMC10316705/
3. National Library of Medicine, PubMed Central. “Poly-D,L-Lactic Acid Filler Increases Extracellular Matrix by Modulating Macrophages and Adipose-Derived Stem Cells in Aged Animal Skin.”
   https://pmc.ncbi.nlm.nih.gov/articles/PMC10294940/
4. National Library of Medicine, PubMed Central. “A Split Face Study Comparing the Effect of a PDLLA-Based Product and PLLA on the Nasolabial Fold.”
   https://pmc.ncbi.nlm.nih.gov/articles/PMC12802405/
5. Mayo Clinic. “Facial Fillers for Wrinkles.”
   https://www.mayoclinic.org/tests-procedures/facial-fillers/about/pac-20394072